Latest news with #MichelleFischbach
Yahoo
08-05-2025
- Politics
- Yahoo
Minneapolis attorney nominated to serve as U.S. Attorney for Minnesota
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Generate Key Takeaways The Brief President Trump has nominated Daniel Rosen to serve as U.S. Attorney for Minnesota. Minnesota GOP representatives are urging their colleagues in the Senate to confirm the nomination. Rosen has 30 years of experience in litigation in federal and state courts and graduated Cum Laude from the University of Minnesota. MINNEAPOLIS (FOX 9) - President Trump has nominated an attorney who runs a law firm in Minneapolis to serve as U.S. Attorney for Minnesota. Daniel Rosen nominated What we know President Trump sent his nomination for Daniel Rosen to serve as U.S. Attorney for Minnesota to Congress on Tuesday. Representatives Tom Emmer, Michelle Fischbach, Pete Stauber, and Brad Finstad announced on Wednesday that they had previously sent a letter to the president, recommending three candidates: Rosen, former U.S. Attorney Erica MacDonald, and attorney Ronald Schutz. Dig deeper Rosen is the principal at Rosen LLC. According to the letter from the lawmakers, Rosen has 30 years of experience in litigation in federal and state courts. "He has used his expertise to advocate for community and charitable issues, especially matters of particular interest to the American Jewish community," Rosen states. "He also served in the United States Navy as a surface warfare officer at sea." The letter also notes Rosen graduated Cum Laude from the University of Minnesota. What they're saying In a joint statement, Reps. Emmer, Stauber, Fischbach, and Finstad wrote: "Dan Rosen is one of the sharpest legal minds in the entire country, and we are thrilled that President Trump has nominated him to serve as the United States Attorney for the District of Minnesota. With over three decades of experience as an attorney and a proven commitment to public safety, Dan will uphold the rule of law and keep criminals off our streets. As fraud and crime run rampant under Governor Walz's watch, we urge our colleagues in the Senate to act quickly to confirm Dan's nomination." The backstory Former U.S. Attorney Andrew Luger resigned from office just days before the Trump presidency. Luger had served under President Obama before stepping down at the request of President Trump during his first term. Luger was then later reappointed under President Biden. The Source This story uses information from GOP news releases and statements from lawmakers.
Yahoo
26-04-2025
- Politics
- Yahoo
Rep. Craig hosts town hall in Fischbach's 7th District
Apr. 25---- Democrat and 2nd District U.S. Rep. Angie Craig hosted a town hall meeting Thursday night in Willmar, part of U.S. Rep. Michelle Fischbach's district, with roughly 100 people in attendance. Constituents of the 7th District have been calling for Fischbach to host a town hall for a little more than two months. According to from Fischbach's office, she hosted a telephone town hall with 14,000 people tuned in. She has not conducted any in-person town halls in her sprawling western Minnesota district that stretches from Canada almost to the Iowa border. "I'm going to listen to your questions to give you some answers to the best of my ability, because Michelle Fischbach won't show up and bring your concerns back to Washington," Craig said. Craig had town halls this week in four cities located in Minnesota congressional districts represented by Republicans. Craig's suburban and southeast Minnesota district includes Scott, Dakota and Le as well as portions of Washington and Rice counties. She noted that her district is one of the most evenly divided congressional districts in the nation, comprising 49% Republican voters and 51% Democratic voters, and said that she has held 72 town halls in her district in the six years she has been in Congress. "I got a whole bunch of Republicans who always show up at my town halls to give me hell, and I welcome them," Craig said. "Now they've shown up so many times I know some of their names, and I always make a point to talk to them after because, at the end of the day, I still believe that most of us have more in common than separates us in this nation." Craig addressed questions on issues that are important to those in the 7th District, including the passage of a farm bill and proposed cuts to Medicaid, the Supplemental Nutrition Assistance Program and Social Security. She also discussed Republicans in Congress being fearful of standing up to what is happening in the executive branch. Craig noted that she was ranked in the top 3% of all bipartisan members of Congress in the last session, stating, "I fundamentally believe if an administration is doing something right, I'm going to cross the aisle and I'm going to work with them. But, if an administration is doing something wrong for my community, for my state, for my country, I also feel an intense responsibility to stand up and speak out and say something." She explained that one of the reasons she is conducting the town halls is because she's "sick and tired" of her Republican colleagues privately complaining about what the Trump administration is doing and then standing idly by and saying nothing about it publicly. "That is not leadership in our country. ... I know they're running scared from the president," she said. Craig noted that Elon Musk has promised to spend his money during the primaries trying to defeat any Republicans who have spoken out against the Department of Government Efficiency and the current administration's actions. Musk is a "special government employee" who has led the DOGE initiative created by executive order. "(Those Republicans) want to keep their jobs. ... If you're not willing to risk your job for what you know is right, then you shouldn't be in the job in the damn first place," Craig said. Minnesota's Congressional District 7 has 165,342 people on Medicaid, the health care program for people with limited income, and 67,000 utilize SNAP, according to Craig, who noted that able-bodied people have to work 20 hours per week to receive benefits from the SNAP, which was formerly known as food stamps. Seventy percent of the people on SNAP are those who are disabled or are seniors, veterans or children, she added. If the Trump administration does not extend the Affordable Care Act tax credits, Craig said that 20,000 people in Congressional District 7 will either lose their health insurance or see a 40% increase in their health insurance costs. Craig is the ranking Democrat member of the House Agriculture Committee, which is responsible for the farm bill. SNAP benefits are tied to the farm bill and the committee has been asked to make $230 billion in cuts to those benefits. "I'm hoping that they are not serious about cutting $230 billion from SNAP. I've been clear to Republicans and to my chairman that it is going to be very, very difficult to get a farm bill across the finish line if they come in and decimate SNAP," Craig said. Craig said the proposed SNAP cuts would decimate the ag economy, hitting the entire supply chain and not just farm income. "(Think about) the grocers and the clerks who put the food on the shelves, the truck drivers who drive it to the grocery stores," she said. "If you take $230 billion out of our food supply chain, not only are you taking food away from hungry veterans and seniors in our country and children in our country, you're also hurting family farms." Congress has also instructed the House Energy and Commerce Committee, which oversees Medicaid spending, to find $880 billion in spending cuts. That figure cannot be reached without cutting Medicaid, according to Democrats and "Gutting Medicaid would increase health care costs for every single American and it would put a lot of people at risk of losing their coverage altogether," Craig said. She explained that these cuts are being made to give a tax break to the top 1% of the wealthiest people in the country and these cuts would actually add $14 trillion to the federal debt over the next 10 years. "To listen to my colleagues talk about fiscal responsibility and waste, fraud and abuse — if you want to talk about those things, let's talk about it, let's have a conversation," Craig said. Craig encouraged those in attendance Thursday to continue to call their representatives, noting that each member of Congress receives detailed reports of who is contacting them and the issues about which they are concerned.
Yahoo
25-03-2025
- Politics
- Yahoo
Entries sought for 2025 Congressional Art Competition
Mar. 25—GRAND FORKS — High school students in Minnesota's Seventh Congressional District are invited to submit entries in the 2025 Congressional Art Competition, U.S. Rep. Michelle Fischbach has announced. Entries must be submitted by 5 p.m. April 16. The winning entries will be displayed in Fischbach's offices in Willmar, Moorhead and Washington, D.C., and the first-place entry will be displayed for one year in the U.S. Capitol. The first-place work hung in the U.S. Capitol will be seen by members of Congress, their staff members, and thousands of visitors from throughout the world, Fischbach said. The art displayed in the Capitol represents the winning artwork from all participating districts around the country. This long-standing, nonpartisan tradition is a wonderful opportunity for students from across the district to showcase their creativity and hard work, Fischbach said in the contest announcement. Students can submit their artwork for the competition by sending a picture of their arts along with a student release form. All entries must be original in concept, design and execution, and may not violate any U.S. copyright laws. The Seventh Congressional District covers the majority of western Minnesota. In this area, the district includes Kittson, Marshall, Norman, Pennington, Polk, Red Lake and Roseau counties. For more information, visit . Since 1982, more than 650,000 high school students from across the nation have participated in the Congressional Art Competition.
Yahoo
17-03-2025
- Politics
- Yahoo
St. Cloud State alumna Fischbach announces 2026 US House of Representatives reelection bid
U.S. Rep. Michelle Fischbach, R-Minn., on Monday launched her campaign to continue representing the North Star State in Washington, D.C. Fischbach, 59, represents Minnesota's seventh congressional district, which includes the western part of Stearns County. She is currently serving her third term after winning her 2024 bid with more than 70% of the vote. "It is a new day in Washington, D.C., with President Trump in the White House and republican majorities in Congress,' Fischbach wrote in a statement. 'We have been given an opportunity by voters to do the things that are needed to save our great nation." The congresswoman is a St. Cloud State University graduate and received her law degree from William Mitchell College of Law in St. Paul. She currently resides in Regal. Environmental politics: Conservation efforts are underway in Stearns County Since her 2020 campaign, Fischbach has advocated for reduced government spending and peeling back federal regulations. She is currently on the House Ways and Means and Rules committees. Fischbach was Minnesota's 49th lieutenant governor. Corey Schmidt covers politics and courts for the St. Cloud Times. He can be reached at cschmidt@ This article originally appeared on St. Cloud Times: US Republican Rep. Michelle Fischbach launches 2026 reelection campaign
Associated Press
17-03-2025
- Business
- Associated Press
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
Seek to clarify that certain hearing implants are prosthetics and therefore not subject to the hearing aid coverage exclusion, allowing for potential Medicare coverage White Bear Lake, Minnesota--(Newsfile Corp. - March 17, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ('Envoy Medical'), a revolutionary hearing health company focused on fully implanted hearing systems, today announced the reintroduction of the Hearing Device Coverage Clarification Act in both the U.S. House of Representatives and U.S. Senate. Representative Michelle Fischbach (R-MN) reintroduced the House version of the bill - H.R. 1921 - along with Representative Angie Craig (D-MN) on March 6, 2025. Senator Amy Klobuchar (D-MN) reintroduced the Senate version of the bill - S. 983 - along with Senator James Lankford (R-OK) on March 13, 2025. Each bill is expected to gain additional bipartisan support. The Hearing Device Coverage Clarification Act seeks to clarify that fully implanted active middle ear hearing devices are prosthetics and not subject to the current Medicare hearing aid coverage exclusion. Such clarification would allow for potential Medicare coverage of implanted hearing devices that are genuinely different from hearing aids such as Envoy Medical's Esteem ® fully implanted active middle ear implant. 'Medicare beneficiaries deserve access to these innovative and breakthrough hearing devices,' said Brent Lucas, CEO of Envoy medical. 'Correcting this administrative mistake is a critical step in the right direction and we are so thankful that Representatives Fischbach and Craig and Senators Klobuchar and Lankford are committed to bringing this issue forward.' Envoy Medical is one of the few companies that currently has a fully implanted active middle implant. It received FDA PMA approval for its Esteem® device in 2010. The Company's headquarters, primary operations, and manufacturing are all located within the United States. The passage of the bills would provide Envoy Medical with an opportunity to create more well-paid American jobs, and increase American competitiveness in the hearing implant industry, which is currently dominated by foreign players. 'We believe coverage of these hearing devices is good domestic policy that would absolutely result in more competition and innovation within the hearing industry,' Lucas added. 'These bills would directly result in more well-paying jobs here in America, but, perhaps more importantly, it would also help to reduce overall healthcare costs as the societal costs of untreated or undertreated hearing loss are just too great to ignore.' About the Fully Implanted Acclaim® Cochlear Implant We believe the fully implanted Acclaim Cochlear Implant ('Acclaim CI') is a first-of-its-kind hearing device. Envoy Medical's fully implanted technology includes a sensor designed to leverage the natural anatomy of the ear instead of a microphone to capture sound. The Acclaim CI is designed to address severe to profound sensorineural hearing loss that is not adequately addressed by hearing aids. The Acclaim CI is expected to be indicated for adults who have been deemed adequate candidates by a qualified physician. The Acclaim Cochlear Implant received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in 2019. CAUTION The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use. About the Esteem® Fully Implanted Active Middle Ear Implant (FI-AMEI) The Esteem fully implanted active middle ear implant (FI-AMEI) is the only FDA-approved, fully implanted* hearing device for adults diagnosed with moderate to severe sensorineural hearing loss allowing for 24/7 hearing capability using the ear's natural anatomy. The Esteem FI-AMEI hearing implant is invisible and requires no externally worn components and nothing is placed in the ear canal for it to function. Unlike hearing aids, you never put it on or take it off. You can't lose it. You don't clean it. The Esteem FI-AMEI hearing implant offers true 24/7 hearing. *Once activated, the external Esteem FI-AMEI Personal Programmer is not required for daily use. Important safety information for the Esteem FI-AMEI can be found at: Copies of the documents filed by Envoy Medical with the SEC may be obtained free of charge at the SEC's website at Forward-Looking Statements This press release includes 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-Looking statements may be identified by the use of words such as 'estimate,' 'plan,' 'project,' 'forecast,' 'intend,' 'will,' 'expect,' 'anticipate,' 'believe,' 'seek,' 'target' or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. Such statements may include, but are not limited to, statements regarding the expectations of Envoy Medical concerning the outlook for its business, productivity, plans and goals for future operational improvements and capital investments; the ability to obtain additional patents and develop future products or product improvements, the Acclaim CI being the first to market fully implanted cochlear implant, the timing and results of clinical trials of the Acclaim CI, and the participation of any institution in such trials; the safety, performance, and market acceptance of the Acclaim CI; the size of Envoy Medical's addressable market, operational performance, future market conditions or economic performance and developments in the capital and credit markets and any information concerning possible or assumed future operations of Envoy Medical; and the effect of proposed legislation on Medicare and insurance reimbursement for the Esteem® device and the impact of any such change to reimbursement policy on the business and financial results of Envoy Medical. The forward-looking statements contained in this press release reflect Envoy Medical's current views about future events and are subject to numerous known and unknown risks, uncertainties, assumptions and changes in circumstances that may cause its actual results to differ significantly from those expressed in any forward-looking statement. Envoy Medical does not guarantee that the events described will happen as described (or that they will happen at all). These forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to changes in the market price of shares of Envoy Medical's Class A Common Stock; changes in or removal of Envoy Medical's shares inclusion in any index; Envoy Medical's success in retaining or recruiting, or changes required in, its officers, key employees or directors; unpredictability in the medical device industry, the regulatory process to approve medical devices, and the clinical development process of Envoy Medical products; competition in the medical device industry, and the failure to introduce new products and services in a timely manner or at competitive prices to compete successfully against competitors; disruptions in relationships with Envoy Medical's suppliers, or disruptions in Envoy Medical's own production capabilities for some of the key components and materials of its products; changes in the need for capital and the availability of financing and capital to fund these needs; changes in interest rates or rates of inflation; legal, regulatory and other proceedings could be costly and time-consuming to defend; changes in applicable laws or regulations, or the application thereof on Envoy Medical; a loss of any of Envoy Medical's key intellectual property rights or failure to adequately protect intellectual property rights; the effects of catastrophic events, including war, terrorism and other international conflicts; and other risks and uncertainties set forth in the section entitled 'Risk Factors' and 'Cautionary Note Regarding Forward Looking Statements' in the Annual Report on Form 10-K filed by Envoy Medical on April 1, 2024, and in other reports Envoy Medical files, with the SEC. If any of these risks materialize or Envoy Medical's assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. While forward-looking statements reflect Envoy Medical's good faith beliefs, they are not guarantees of future performance. Envoy Medical disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based only on information currently available to Envoy Medical. Investor Relations: Media Contact:
